Gout Incidence Down With SGLT2 Inhibitors in Type 2 Diabetes
Gout incidence rate significantly reduced with SGLT2 inhibitor vs GLP-1 receptor agonist.
Diabetes
Telemedicine Visits Comparable for Glycemic Control in T1DM
Telemedicine instead of office visit did not change outcomes in patients with suboptimal glycemic control.
Bariatric Surgery May Aid T2DM-Related Outcomes at 5 Years
Benefits seen for diabetes remission, weight loss, changes in metabolic parameters.
Experts Weigh In on the Best Diets for 2020
The Mediterranean Diet was ranked as the best diet overall for 2020, according to new rankings released by US News and World Report.
Coffee Consumption Does Not Affect Insulin Sensitivity
Consumption of 4 cups of coffee per day linked to loss of fat mass, reduction in urinary creatinine.
Fiasp Approved for Pediatric Patients With Diabetes
The approval was based on data from an active-controlled, treat-to-target trial (Onset7) that included 777 pediatric patients (aged 2 to 17 years) with type 1 diabetes.
Prenatal Smoking Raises Risk for Gestational Diabetes Mellitus
Increased risk for GDM seen across all levels of prepregnancy BMI and gestational weight gain.
ADA 2020 Standards of Care Incorporate CVD Risk Stratification, New Medications
The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.
Consuming Ultraprocessed Food May Up Risk for Type 2 Diabetes
Significant links persisted after adjustment for markers of nutritional quality, metabolic comorbidities.
Toujeo Approved for Pediatric Patients With Diabetes
The FDA has expanded the indication for Toujeo (insulin glargine; Sanofi) 300 Units/mL to include treatment of pediatric patients aged ≥6 years with diabetes mellitus.
Next post in Diabetes Information Center
